Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia-Reference-Cited by-同舟云学术

Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia

Published:2020-12-14 Issue:4 Volume:28 Page:1142-1152
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Álvarez Ignacio¹²^ORCID,Diez‐Fairen Monica¹²,Aguilar Miquel¹²,González Jose Manuel³,Ysamat Montse³,Tartari Juan Pablo¹²,Carcel Maria¹²,Alonso Alvaro⁴,Brix Britta⁵,Arendt Philipp⁵,Pastor Pau¹²^ORCID

Affiliation:

1. Memory Disorders Unit Department of Neurology Hospital Universitari Mutua de Terrassa Terrassa Spain

2. Fundació per a la Recerca Biomèdica i Social Mútua de Terrassa Terrassa Spain

3. Centre de Tecnologia Diagnòstica Hospital Universitari Mutua de Terrassa Terrassa Spain

4. Department of Epidemiology Rollins School of Public Health Emory University Atlanta Georgia USA

5. Institute of Experimental Immunology affiliated to EUROIMMUN Medizinische Labordiagnostika AG Luebeck Germany

Funder

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14658

Reference53 articles.

1. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

2. Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40

3. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

4. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

5. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis;Alzheimer's Research & Therapy;2024-09-06

2. A genetic and proteomic comparison of key AD biomarkers across tissues;Alzheimer's & Dementia;2024-07-30

3. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease;Molecular Neurodegeneration;2024-01-03

4. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease;2023-06-20

5. Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study;Pharmaceutics;2023-03-12